---
title: "Hunan High-Tech Industry Investment chair Li Aidong visits Tianjin Pharma for operations review"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295429562.md"
description: "Li Aidong, chair of Hunan Pharmaceutical Development Private Equity Fund Management, visited Tianjin Pharmaceutical on Aug. 7, 2026, for an operational review. Discussions focused on 2026 performance and the '15th Five-Year Plan,' emphasizing capacity expansion and quality control. Li urged faster execution to meet targets and strengthen core technologies. The fund pledged support in R&D, market expansion, and restructuring to accelerate Tianjin Pharmaceutical's growth."
datetime: "2026-08-10T16:09:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295429562.md)
  - [en](https://longbridge.com/en/news/295429562.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295429562.md)
generator: "portal-rs"
---

# Hunan High-Tech Industry Investment chair Li Aidong visits Tianjin Pharma for operations review

-   Hunan Pharmaceutical Development Private Equity Fund Management chair Li Aidong visited portfolio company Tianjin Pharmaceutical on Aug. 7, 2026 for an operational review. \* Management discussed 2026 performance and its “15th Five-Year Plan” strategy, highlighting capacity ramp-up, standardized manufacturing, quality controls. \* Li urged faster execution to close operational gaps, push reforms, strengthen core technology, build brands, expand sales channels, meet annual targets. \* The fund manager pledged support for Tianjin Pharmaceutical in R&D, market expansion, restructuring to accelerate growth. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hunan Pharmaceutical Development Private Equity Fund Management Co Ltd published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [600329.CN](https://longbridge.com/en/quote/600329.CN.md)
- [T14.SG](https://longbridge.com/en/quote/T14.SG.md)

## Related News & Research

- [Tianjin Pharmaceutical Da Ren Tang enters annual distribution deal with Taiping Medicine, Zhongxin Medicine](https://longbridge.com/en/news/295236477.md)
- [Zhongtian Construction (Hunan) schedules board meeting to review interim results, consider dividend](https://longbridge.com/en/news/296457933.md)
- [NACCO subsidiary Coteau Properties receives MSHA imminent danger order at Freedom Mine](https://longbridge.com/en/news/296401808.md)
- [Core Natural Resources SVP, CFO Nathan J. Tucker files initial beneficial ownership statement](https://longbridge.com/en/news/296511798.md)
- [Cell C publishes pro forma financials after Comm Equipment Company merger](https://longbridge.com/en/news/296585930.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**